Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

ADVANCING CLINICAL TRIALS AND EPIDEMIC PREPAREDNESS RESEARCH CAPACITY IN AFRICA (ACT-PREP)

Objective

Infectious diseases such as COVID-19 and Ebola are leading contributors to the high morbidity and mortality in sub-Saharan African (SSA), yet these countries have inadequate capacity to rapidly conduct clinical trials and other public research in preparedness and epidemic response. The ACT-PREP initiative seeks to enhance clinical research capacities for preparedness and response in SSA. With leadership from Makerere University School of Public Health, ACT-PREP will create a framework for equitable collaboration among 10 diverse African and 2 European institutions working closely with national public health institutes and Africa CDC to enhance disease surveillance, detection, and institutionalise research as a critical pillar of disease response. ACT-PREP will strengthen capacities of partner institutions and actors in the research regulatory ecosystem and integrate the training into PhD and PostDoc training to reach more young researchers. ACT-PREP will promote sharing of expertise, experience, resources, datasets, and technology within and across countries to strengthen clinical research, ethics and regulatory capacities, and upgrade laboratory and surveillance systems across institutions and countries in SSA. The research capacity enhancement will adapt a framework from our previous work between Makerere University and Karolinska Institute and the WHO Alliance for Health Policy and Systems Research framework. Additional strategies will include One health & AI systems to guide prediction, detection and rapid response to epidemics, and streamlined regulatory processes for timely clinical trial deployment and monitoring. This network will leverage immense in-kind resources from partners to train at least 100 fellows/other trainees annually, strengthen regional collaboration and capacity to conduct high quality trials, significantly advance epidemic preparedness and response and ultimately lower morbidity and mortality due to infectious diseases in SSA.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Keywords

Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

HORIZON-JU-CSA - HORIZON JU Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) HORIZON-JU-GH-EDCTP3-2025-03-two-stage

See all projects funded under this call

Coordinator

EUROPEAN & DEVELOPING COUNTRIES CLINICAL TRIALS PARTNERSHIP
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 0,98
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (12)

Partners (1)

My booklet 0 0